SCP
TDOC icon

Sender Company & Partners’s Teladoc Health TDOC Stock Holding History

Sender Company & Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-172,800
Closed -$1.34M – 409
2025
Q3 		$1.34M Buy
172,800
+146,800
+565% +$1.15M 0.15% 169
2025
Q2 		$226K Buy
+26,000
New +$188K 0.06% 235

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Sender Company & Partners's TDOC Position: Q4 2025 in Review

Sender Company & Partners sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 43,176 shares — an estimated $334K sold.

Sender Company & Partners first reported a position in TDOC in Q2 2024 and held it in 3 quarters. The position peaked at $1.04M in Q2 2024. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Sender Company & Partners reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Sender Company & Partners sold 43,176 Teladoc Health shares in Q4 2025, an estimated $334K.
  • Sender Company & Partners first reported a position in Teladoc Health in Q2 2024 and held it in 3 quarters.
  • Sender Company & Partners's Teladoc Health position peaked at $1.04M in Q2 2024.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Sender Company & Partners's 13F filing for Q4 2025, filed 17 Feb 2026.